Advertisement

Index by author

September 01, 1988; Volume 34,Issue 3

  1. Lawson, J A

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  2. Leid, M

    1. Characterization of agonist radioligand interactions with porcine atrial A1 adenosine receptors.
      M Leid, M I Schimerlik and T F Murray
      Molecular Pharmacology September 1988, 34 (3) 334-339;

  3. Lenzen, S

    1. Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme.
      S Lenzen, S Freytag and U Panten
      Molecular Pharmacology September 1988, 34 (3) 395-400;

  4. Loew, G H

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  5. Lucier, G W

    1. Smoking-related alterations in epidermal growth factor and insulin receptors in human placenta.
      S L Wang, G W Lucier, R B Everson, G I Sunahara and K T Shiverick
      Molecular Pharmacology September 1988, 34 (3) 265-271;

  6. Luthin, G R

    1. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
      G R Luthin, J Harkness, R P Artymyshyn and B B Wolfe
      Molecular Pharmacology September 1988, 34 (3) 327-333;
Back to top

In this issue

Advertisement